Allergan's add-on treatment for depression fails late-stage studies

Singapore News News

Allergan's add-on treatment for depression fails late-stage studies
Singapore Latest News,Singapore Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 66%

Allergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage ...

REUTERS: Allergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage studies.

The trials evaluated the efficacy, safety and tolerability of Allergan's treatment, rapastinel, compared to a placebo, both in combination with antidepressant therapy in patients with depression who had a partial response to ADT, the company said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Mike Ashley's Sports Direct offers to buy Britain's FindelMike Ashley's Sports Direct offers to buy Britain's FindelBritish retail tycoon Mike Ashley's Sports Direct International Plc said on Monday it will offer to buy Findel Plc in a deal that values the ...
Read more »

ImmunoGen's ovarian cancer drug fails in late-stage studyImmunoGen's ovarian cancer drug fails in late-stage studyREUTERS: U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.
Read more »

Alnylam's gene-silencing drug meets main goal in late-stage studyAlnylam's gene-silencing drug meets main goal in late-stage studyREUTERS: Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a ...
Read more »

FDA approves J&J's ketamine-like nasal spray for depressionFDA approves J&J's ketamine-like nasal spray for depressionREUTERS: The U.S. Food and Drug Administration on Tuesday said it approved Johnson & Johnson's nasal spray antidepressant that is chemically ...
Read more »

Vaginal laser treatment tied to complications like scarringVaginal laser treatment tied to complications like scarring(Reuters Health) - Vaginal laser treatments may help relieve problems associated with menopause, like dryness, pain and sexual dysfunction, but ...
Read more »

Trump to drop preferential trade treatment for India; Delhi plays down impactTrump to drop preferential trade treatment for India; Delhi plays down impactU.S. President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India ...
Read more »

Australia to send 57 refugees deemed a threat to island detention site for treatmentAustralia to send 57 refugees deemed a threat to island detention site for treatmentSYDNEY: Fifty-seven male asylum seekers deemed to be a security risk will be sent to a remote Pacific island detention centre for medical ...
Read more »

Trump to end special trade treatment for IndiaTrump to end special trade treatment for IndiaWASHINGTON/NEW DELHI US President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India that allows duty-free entry for up to US$5.6 billion (S$7.6 billion) worth of its exports to the US. India...
Read more »

Ebola treatment center in Congo reopens after attack: ministryEbola treatment center in Congo reopens after attack: ministryKINSHASA: An Ebola treatment center at the epicenter of the current outbreak in eastern Democratic Republic of Congo has resumed operations after ...
Read more »



Render Time: 2025-03-13 22:54:10